Spirit Scientific Co., Ltd. (TPEX:7790)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
69.00
+7.50 (12.20%)
At close: Feb 11, 2026
Market Cap1.22B +6.9%
Revenue (ttm)279.34M +33.9%
Net Income20.14M +264.3%
EPS1.15 +231.7%
Shares Out17.70M
PE Ratio60.16
Forward PEn/a
Dividend0.07 (0.10%)
Ex-Dividend Daten/a
Volume17,235
Average Volume9,089
Open61.50
Previous Close61.50
Day's Range61.50 - 69.00
52-Week Range55.00 - 87.30
Betan/a
RSI61.68
Earnings DateApr 16, 2026

About Spirit Scientific

Spirit Scientific Co., Ltd., a med-tech company, focuses on minimal invasive treatment for orthopedic pain relief. It offers Vessel-X, a bone filling containment system to treat patients with spinal compression fractures; Osteo-G, treatment for spinal compression fractures; cryo-crystal related products; various orthopedic medical devices; and platelet-lyophilized-treatment technology for the treatment of osteoarthritis and sports injuries. The company was founded in 2013 and is based in Taipei, Taiwan. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Employees 81
Stock Exchange Taipei Exchange
Ticker Symbol 7790
Full Company Profile

Financial Performance

In 2024, Spirit Scientific's revenue was 226.39 million, an increase of 26.57% compared to the previous year's 178.86 million. Earnings were 5.05 million, an increase of 0.20%.

Financial Statements